Intracranial Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2026

 

Intracranial stenosis refers to blood vessel narrowing or blood clots brought on by the accumulation of fats, plaque, and other substances in the blood vessels. A stroke to either the intracranial artery or the carotid artery in the neck characterizes this condition. Stents are used in this condition as a permanent implants to open the blocked arteries and allow blood to flow to the brain. For patients who have experienced a stroke or transient ischemic attack, angioplasty (the use of a balloon catheter) and Intracranial Stents Market may be the best course of treatment (TIA). However, because these stents are made for use in the heart, using them in the arteries of the brain is challenging.

In the case of wide-neck intracranial aneurysms, the Acclino microstent from Acandis GmbH exhibits a promising rate of immediate and mid-term complete aneurysm occlusion and a satisfactory safety profile.

The rise in intracranial stent use for the treatment of Intracranial Stents Market and the management of stroke due to the rising prevalence of high blood pressure, as well as the rising demand for minimally invasive intracranial surgery, are the factors driving the global intracranial stent market during the forecasted period. The expansion of the elderly population and the development of the healthcare sector, along with increased government spending to build out healthcare infrastructure and the rising adoption of technologically Advanced Intracranial Stents, are also contributing to the growth of the global intracranial stents market.

Key Players

The top companies in the world market for intracranial stents are Medtronic Plc, Balt Extrusion S.A., MicroPort Scientific Corporation, Abbott Laboratories, Stryker Corporation, Admedes Schuessler GmbH, Cardiatis, S.A, DePuy Synthes, Acandis GmbH, and Penumbra, Inc.